CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 3,045.2	$ 1,132.3
Short-term investments (Note 8)	930.7	500.5
Accounts receivable, net of allowances of $11.6 and $8.2, respectively	609.1	771.5
Other receivables	118.3	56.6
Inventories (Note 6)	1,086.7	903.5
Prepaid expenses	121.0	128.8
Other current assets	347.6	224.9
Current assets of discontinued operations (Note 5)	26.8	317.6
Total current assets	6,285.4	4,035.7
Long-term investments (Note 8)	307.9	583.9
Property, plant, and equipment, net (Note 6)	1,686.0	1,591.0
Operating lease right-of-use assets (Note 7)	98.2	84.4
Goodwill (Note 11)	1,776.7	1,145.1
Other intangible assets, net (Note 11)	1,176.6	399.4
Deferred income taxes	992.1	749.4
Other assets	721.6	463.2
Non-current assets of discontinued operations (Note 5)	10.8	311.1
Total assets	13,055.3	9,363.2
Current liabilities
Accounts payable	197.4	186.6
Accrued and other liabilities (Note 6)	1,282.4	856.4
Operating lease liabilities (Note 7)	23.4	22.9
Current liabilities of discontinued operations (Note 5)	2.0	129.5
Total current liabilities	1,505.2	1,195.4
Long-term debt (Note 12)	597.7	597.0
Contingent consideration liabilities (Note 13)	14.5	0.0
Taxes payable (Note 19)	1.3	80.6
Operating lease liabilities (Note 7)	78.9	65.2
Uncertain tax positions (Note 19)	384.6	335.0
Litigation settlement accrual (Note 3)	52.7	94.2
Other liabilities	357.5	251.3
Non-current liabilities of discontinued operations (Note 5)	0.0	25.1
Total liabilities	2,992.4	2,643.8
Commitments and contingencies (Notes 7, 12, and 20)
Stockholders' equity (Note 16)
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding	0.0	0.0
Common stock, $1.00 par value, 1,050.0 shares authorized, 654.8 and 650.5 shares issued, and 588.6 and 601.1 shares outstanding, respectively	654.8	650.5
Additional paid-in capital	2,613.4	2,274.4
Retained earnings	13,167.0	8,992.4
Accumulated other comprehensive loss (Note 17)	(244.5)	(242.8)
Treasury stock, at cost, 66.2 and 49.4 shares, respectively	(6,192.3)	(5,024.5)
Total Edwards Lifesciences Corporation stockholders' equity	9,998.4	6,650.0
Noncontrolling interest	64.5	69.4
Total stockholders' equity	10,062.9	6,719.4
Total liabilities and equity	$ 13,055.3	$ 9,363.2